A bridge round is not successful because it adds six or nine months of runway. It is successful when those months produce evidence that changes the company’s next financing, strategic or operating choice. Without that evidence, the bridge may simply finance another round of the same uncertainty.

The phrase “bridge round” sounds temporary and reassuring. It suggests a short crossing between a known present and a better-financed future. Yet the destination is often less defined than the instrument.

For a board, the first task is therefore not to choose between equity, a convertible note, a SAFE-like instrument or another structure. It is to specify the decision the new money must make possible. Instrument selection follows from that objective, the company’s jurisdiction, capital structure and stakeholder constraints.

Name the proof point

A useful bridge finances a test that can succeed or fail within the available runway. Depending on the company, that may be regulatory approval, a completed product release, contracted recurring revenue, a gross-margin threshold, customer retention across a renewal cycle, production validation, a strategic partnership or a defined cost base.

“More growth” is not a proof point. Neither is “being ready for Series B”. Both are aspirations. A proof point has an owner, a measurement method, a date and a consequence.

The board should ask: if the company reaches this milestone, what becomes possible that is not possible today? Better evidence may support a larger institutional round, a strategic process, bankability or a narrower operating plan. If the milestone does not change any future counterparty’s decision, the bridge may not be buying enough.

Build runway from sources and uses, not from the bank balance

Runway is frequently calculated as cash divided by current monthly burn. That is a starting point, not a financing plan.

A bridge model should show opening cash, gross proceeds, transaction costs, monthly operating cash use, working-capital swings, capital expenditure, debt service, taxes and a minimum liquidity floor. It should include the cost of reaching the proof point and the time needed to prepare the next transaction after the proof point has been observed.

That last interval is routinely underestimated. Data must be assembled, investors or strategic counterparties engaged, diligence completed, documents negotiated and funds received. A bridge that reaches the milestone with no cash left for the next process has not completed the crossing.

The downside case matters more than an optimistic month count. What happens if sales close later, collections stretch, hiring savings take time or the next round does not occur? Which expenditures can genuinely be stopped, and which are contractual or operationally necessary?

Price dilution and control together

The economic cost of a bridge is not captured by the headline amount.

An equity round crystallises a valuation and ownership now. A convertible note can add interest, maturity and repayment or conversion mechanics. A SAFE is not simply a note without interest: the SEC describes SAFEs among common startup securities, and Y Combinator publishes specific SAFE forms with stated terms; characteristics vary and are jurisdiction-specific. Discounts, valuation caps, most-favoured-nation provisions, pro rata rights, seniority, liquidation economics, board rights, vetoes and information rights can all affect the next round.

These instruments do not travel unchanged across jurisdictions. Legal form, regulatory treatment, tax, accounting and enforceability require advice for the company and investors concerned. The board’s role is to understand the cap-table and governance outcomes across scenarios, not to rely on the shorthand name of the instrument.

At minimum, model the bridge converting at the cap, at the next-round price with the discount, and in a scenario with no qualifying financing. Show fully diluted ownership and control rights after each outcome.

Decide the downside before the money arrives

A bridge should include a decision calendar, not only a budget.

One date tests whether the proof point is on track. Another determines whether the next financing process should begin. A third triggers a downside plan: lower spend, a narrower product, strategic alternatives, an asset sale or an orderly wind-down. The appropriate alternatives depend on the company; the discipline is to define them while the board still has choices.

Existing shareholders also need to decide what participation means. Supporting the bridge may protect the option value of prior investment, but it can also increase exposure to a plan whose underlying evidence has not improved. Non-participation may create dilution or governance consequences. Those are investment decisions for each shareholder, not a reason to assume that insiders will fund the company again.

Six tests for a credible bridge

Decision: Which exact future choice will the bridge make better informed?
Evidence: What proof point will be observed, by when and by whom?
Runway: Does cash cover both the proof point and the transaction period that follows?
Economics: What happens to ownership, priority and returns under each conversion or financing scenario?
Governance: Which rights change now, and could they complicate the next round or strategic process?
Downside: What action begins if the milestone is late, missed or insufficient to unlock funding?

A bridge is most valuable when it converts uncertainty into evidence. It is least valuable when it converts a difficult decision into a later difficult decision with less cash, a more complicated cap table and fewer strategic options.

CGPH Banque d’affaires supports companies and shareholders with capital-readiness assessment, financial analysis, capital planning, transaction materials and process coordination within an agreed mandate. Investor participation, pricing, allocation, legal documentation and completion remain decisions and responsibilities of the relevant investors, institutions and qualified or authorised parties.

Sources

This article is for general information only and does not constitute investment, financing, legal, tax, accounting or regulatory advice.